Written question WQ91340
- Asked by
- Rhys ab OwenIndependent
- To be answered by
- Minister for Health and Social Services
- Tabled
- Due
- Answered
- Time to answer
- 12 days
Question
What steps is the Minister taking to ensure that the process of licensing lecanemab and donanemab will be fast and efficient, but not impinge on the safety of patients with Alzheimer’s?
Answer
Answered by Minister for Rural Affairs and North Wales, and Trefnydd
Lecanemab and donanemab are not yet licensed for use in the UK. The licensing of medicines is a reserved matter and is the responsibility of the Medicines and Healthcare products Regulatory Agency (MHRA).